Cardiometabolic

Cardiology is the branch of medicine involving the study, diagnosis and treatment of acquired or congenital cardiovascular diseases, which represent the primary cause of mortality and morbidity in Western countries. In addition to treating cardiovascular diseases, heart failure and rhythm disorders, cardiologists also deal with cardiovascular prevention.

Over the past two decades, there has been increased interest in omega-3 polyunsaturated fatty acids (PUFA), on account of their lipid-lowering, anti-inflammatory, antiarrhythmic and antithrombotic properties. In addition to being introduced through the diet, omega-3s extracted from fish oils can be prescribed by doctors as medicinal products for the treatment of certain medical conditions.

IBSA uses omega-3 fatty acids (EPA/DHA) that have been certified as a sustainable source by Friends of the Sea and have received IFOS Five Star certification for their purity,  freshness and concentration, which are preserved by using soft capsules.

For the cardio-metabolic area, in case of cardio-metabolic diseases, IBSA also recently developed two nutraceutical formulations, whose ingredients include monacolin k, which facilitates the maintenance of normal plasma cholesterol levels.